Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan in Haemodialysed Patients With Chronic Heart Failure
NCT00490958Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Telmisartan + ACE inhibitor with Placebo + ACE inhibitor (2 arms). Primary endpoints: All-cause mortality at 36 months, Cardiovascular mortality at 36 months and 1 more. Started Jan 1999; status: completed.
02
Drugs
telmisartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00490958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490958.